|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/24 | |
| A61K 39/00 | |||
| G01N 33/68 |
| (11) | Number of the document | 3164414 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15731976.5 |
| Date of filing the European patent application | 2015-07-01 | |
| (97) | Date of publication of the European application | 2017-05-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/064931 |
| Date | 2015-07-01 |
| (87) | Number | WO 2016/001275 |
| Date | 2016-01-07 |
| (30) | Number | Date | Country code |
| 14175361 | 2014-07-02 | EP |
| (72) |
VICARI, Alain, FR
LEGER, Olivier, FR
|
| (73) |
Calypso Biotech SA,
Chemin des Aulx, 14, 1228 Plan-les-Ouates,
CH
|
| (54) | ANTIBODIES TO IL-15 |
| ANTIBODIES TO IL-15 |